$ADMP Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Adamis Pharmaceuticals Corp.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Adamis Pharmaceuticals Corp. Get notifications about new insider transactions in Adamis Pharmaceuticals Corp for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 23 2021 | ADMP | Adamis Pharmaceuti ... | Hopkins Robert O | Chief Financial Off ... | Option Exercise | M | 0.00 | 22,258 | 0 | 0 | |
Feb 23 2021 | ADMP | Adamis Pharmaceuti ... | Hopkins Robert O | Chief Financial Off ... | Buy | M | 0.00 | 22,258 | 0 | 277,067 | 254.8 K to 277.1 K (+8.74 %) |
Feb 23 2021 | ADMP | Adamis Pharmaceuti ... | Marguglio David J. | SVP and Chief Busin ... | Option Exercise | M | 0.00 | 22,258 | 0 | 0 | |
Feb 23 2021 | ADMP | Adamis Pharmaceuti ... | Marguglio David J. | SVP and Chief Busin ... | Buy | M | 0.00 | 22,258 | 0 | 309,522 | 287.3 K to 309.5 K (+7.75 %) |
Feb 23 2021 | ADMP | Adamis Pharmaceuti ... | Moss Ronald B. | Chief Medical Offic ... | Option Exercise | M | 0.00 | 13,911 | 0 | 0 | |
Feb 23 2021 | ADMP | Adamis Pharmaceuti ... | Moss Ronald B. | Chief Medical Offic ... | Buy | M | 0.00 | 13,911 | 0 | 245,663 | 231.8 K to 245.7 K (+6.00 %) |
Feb 23 2021 | ADMP | Adamis Pharmaceuti ... | CARLO DENNIS J PHD | President & CEO | Option Exercise | M | 0.00 | 27,822 | 0 | 0 | |
Feb 23 2021 | ADMP | Adamis Pharmaceuti ... | CARLO DENNIS J PHD | President & CEO | Buy | M | 0.00 | 27,822 | 0 | 344,227 | 316.4 K to 344.2 K (+8.79 %) |
Nov 20 2020 | ADMP | Adamis Pharmaceuti ... | Moss Ronald B. | Chief Medical Offic ... | Sell | S | 0.41 | 8,532 | 3,465 | 231,752 | 240.3 K to 231.8 K (-3.55 %) |
Nov 20 2020 | ADMP | Adamis Pharmaceuti ... | Hopkins Robert O | Chief Financial Off ... | Sell | S | 0.41 | 7,229 | 2,936 | 289,810 | 297 K to 289.8 K (-2.43 %) |
Nov 20 2020 | ADMP | Adamis Pharmaceuti ... | CARLO DENNIS J PHD | President & CEO | Sell | S | 0.41 | 10,665 | 4,331 | 316,405 | 327.1 K to 316.4 K (-3.26 %) |
Nov 20 2020 | ADMP | Adamis Pharmaceuti ... | Daniels Karen K. | VP of Operations | Sell | S | 0.41 | 5,333 | 2,166 | 149,242 | 154.6 K to 149.2 K (-3.45 %) |
Nov 20 2020 | ADMP | Adamis Pharmaceuti ... | Marguglio David J. | SVP and Chief Busin ... | Sell | S | 0.41 | 8,532 | 3,465 | 322,264 | 330.8 K to 322.3 K (-2.58 %) |
Aug 20 2020 | ADMP | Adamis Pharmaceuti ... | Marguglio David J. | SVP and Chief Busin ... | Sell | S | 0.87 | 8,749 | 7,648 | 328,539 | 337.3 K to 328.5 K (-2.59 %) |
Aug 20 2020 | ADMP | Adamis Pharmaceuti ... | Hopkins Robert O | Chief Financial Off ... | Sell | S | 0.87 | 7,418 | 6,484 | 294,781 | 302.2 K to 294.8 K (-2.45 %) |
Aug 20 2020 | ADMP | Adamis Pharmaceuti ... | CARLO DENNIS J PHD | President & CEO | Sell | S | 0.87 | 10,929 | 9,553 | 299,247 | 310.2 K to 299.2 K (-3.52 %) |
Aug 20 2020 | ADMP | Adamis Pharmaceuti ... | Moss Ronald B. | Chief Medical Offic ... | Sell | S | 0.87 | 8,749 | 7,648 | 226,373 | 235.1 K to 226.4 K (-3.72 %) |
Aug 20 2020 | ADMP | Adamis Pharmaceuti ... | Daniels Karen K. | VP of Operations | Sell | S | 0.87 | 5,480 | 4,790 | 140,664 | 146.1 K to 140.7 K (-3.75 %) |
May 20 2020 | ADMP | Adamis Pharmaceuti ... | Hopkins Robert O | Chief Financial Off ... | Sell | S | 0.56 | 6,532 | 3,659 | 302,199 | 308.7 K to 302.2 K (-2.12 %) |
May 20 2020 | ADMP | Adamis Pharmaceuti ... | Marguglio David J. | SVP and Chief Busin ... | Sell | S | 0.56 | 7,734 | 4,332 | 337,288 | 345 K to 337.3 K (-2.24 %) |
May 20 2020 | ADMP | Adamis Pharmaceuti ... | Moss Ronald B. | Chief Medical Offic ... | Sell | S | 0.56 | 7,736 | 4,333 | 235,122 | 242.9 K to 235.1 K (-3.19 %) |
May 20 2020 | ADMP | Adamis Pharmaceuti ... | Daniels Karen K. | VP of Operations | Sell | S | 0.56 | 4,855 | 2,719 | 146,144 | 151 K to 146.1 K (-3.22 %) |
May 20 2020 | ADMP | Adamis Pharmaceuti ... | CARLO DENNIS J PHD | President & CEO | Sell | S | 0.56 | 9,913 | 5,552 | 310,176 | 320.1 K to 310.2 K (-3.10 %) |
Mar 19 2020 | ADMP | Adamis Pharmaceuti ... | Moss Ronald B. | Chief Medical Offic ... | Sell | S | 0.34 | 10,337 | 3,479 | 242,858 | 253.2 K to 242.9 K (-4.08 %) |
Mar 19 2020 | ADMP | Adamis Pharmaceuti ... | Marguglio David J. | SVP and Chief Busin ... | Sell | S | 0.34 | 10,337 | 3,479 | 325,022 | 335.4 K to 325 K (-3.08 %) |
Mar 19 2020 | ADMP | Adamis Pharmaceuti ... | Hopkins Robert O | Chief Financial Off ... | Sell | S | 0.34 | 8,749 | 2,945 | 308,731 | 317.5 K to 308.7 K (-2.76 %) |
Mar 19 2020 | ADMP | Adamis Pharmaceuti ... | Daniels Karen K. | VP of Operations | Sell | S | 0.34 | 6,461 | 2,175 | 150,999 | 157.5 K to 151 K (-4.10 %) |
Mar 19 2020 | ADMP | Adamis Pharmaceuti ... | CARLO DENNIS J PHD | President & CEO | Sell | S | 0.34 | 10,645 | 3,583 | 320,089 | 330.7 K to 320.1 K (-3.22 %) |
Feb 26 2020 | ADMP | Adamis Pharmaceuti ... | CARLO DENNIS J PHD | President & CEO | Sell | S | 0.60 | 12,436 | 7,505 | 330,734 | 343.2 K to 330.7 K (-3.62 %) |
Feb 26 2020 | ADMP | Adamis Pharmaceuti ... | Marguglio David J. | SVP and Chief Busin ... | Sell | S | 0.60 | 9,948 | 6,004 | 335,359 | 345.3 K to 335.4 K (-2.88 %) |
Feb 26 2020 | ADMP | Adamis Pharmaceuti ... | Hopkins Robert O | Chief Financial Off ... | Sell | S | 0.60 | 8,420 | 5,081 | 317,480 | 325.9 K to 317.5 K (-2.58 %) |
Feb 26 2020 | ADMP | Adamis Pharmaceuti ... | Daniels Karen K. | VP of Operations | Sell | S | 0.60 | 6,229 | 3,759 | 157,460 | 163.7 K to 157.5 K (-3.81 %) |
Feb 26 2020 | ADMP | Adamis Pharmaceuti ... | Moss Ronald B. | Chief Medical Offic ... | Sell | S | 0.06 | 6,229 | 396 | 253,195 | 259.4 K to 253.2 K (-2.40 %) |
Feb 13 2020 | ADMP | Adamis Pharmaceuti ... | Blunt Roshawn A. | Director | Option Exercise | A | 0.97 | 50,000 | 48,500 | 50,000 | |
Nov 20 2019 | ADMP | Adamis Pharmaceuti ... | Hopkins Robert O | Chief Financial Off ... | Sell | S | 0.83 | 7,347 | 6,099 | 325,900 | 333.2 K to 325.9 K (-2.20 %) |
Nov 20 2019 | ADMP | Adamis Pharmaceuti ... | Moss Ronald B. | Chief Medical Offic ... | Sell | S | 0.85 | 8,448 | 7,198 | 259,424 | 267.9 K to 259.4 K (-3.15 %) |
Nov 20 2019 | ADMP | Adamis Pharmaceuti ... | Daniels Karen K. | VP of Operations | Sell | S | 0.83 | 5,421 | 4,499 | 163,689 | 169.1 K to 163.7 K (-3.21 %) |
Nov 20 2019 | ADMP | Adamis Pharmaceuti ... | Marguglio David J. | SVP and Chief Busin ... | Sell | S | 0.87 | 8,283 | 7,197 | 365,307 | 373.6 K to 365.3 K (-2.22 %) |
Nov 20 2019 | ADMP | Adamis Pharmaceuti ... | CARLO DENNIS J PHD | President & CEO | Sell | S | 0.84 | 10,760 | 8,999 | 343,170 | 353.9 K to 343.2 K (-3.04 %) |
Oct 10 2019 | ADMP | Adamis Pharmaceuti ... | BIRNDORF HOWARD C | Director | Option Exercise | A | 0.97 | 50,000 | 48,500 | 50,000 | |
Aug 21 2019 | ADMP | Adamis Pharmaceuti ... | CARLO DENNIS J PHD | President & CEO | Sell | S | 1.06 | 10,477 | 11,117 | 353,930 | 364.4 K to 353.9 K (-2.88 %) |
Aug 21 2019 | ADMP | Adamis Pharmaceuti ... | Hopkins Robert O | Chief Financial Off ... | Sell | S | 1.06 | 7,101 | 7,536 | 333,247 | 340.3 K to 333.2 K (-2.09 %) |
Aug 21 2019 | ADMP | Adamis Pharmaceuti ... | Daniels Karen K. | VP of Operations | Sell | S | 1.06 | 5,243 | 5,558 | 169,110 | 174.4 K to 169.1 K (-3.01 %) |
Aug 21 2019 | ADMP | Adamis Pharmaceuti ... | Marguglio David J. | SVP and Chief Busin ... | Sell | S | 1.10 | 8,109 | 8,883 | 373,590 | 381.7 K to 373.6 K (-2.12 %) |
Aug 21 2019 | ADMP | Adamis Pharmaceuti ... | Moss Ronald B. | Chief Medical Offic ... | Sell | S | 1.06 | 8,383 | 8,893 | 267,872 | 276.3 K to 267.9 K (-3.03 %) |
May 28 2019 | ADMP | Adamis Pharmaceuti ... | DENBY WILLIAM C | Buy | P | 1.60 | 6,250 | 9,997 | 108,750 | 102.5 K to 108.8 K (+6.10 %) | |
May 28 2019 | ADMP | Adamis Pharmaceuti ... | WILLIAMS RICHARD C | Buy | P | 1.57 | 50,000 | 78,520 | 239,918 | 189.9 K to 239.9 K (+26.33 %) | |
May 28 2019 | ADMP | Adamis Pharmaceuti ... | ROTHERMEL ROBERT B | Buy | P | 1.58 | 6,500 | 10,270 | 133,500 | 127 K to 133.5 K (+5.12 %) | |
May 22 2019 | ADMP | Adamis Pharmaceuti ... | CARLO DENNIS J PHD | President & CEO | Sell | S | 1.73 | 11,184 | 19,339 | 364,407 | 375.6 K to 364.4 K (-2.98 %) |
May 22 2019 | ADMP | Adamis Pharmaceuti ... | Daniels Karen K. | VP of Operations | Sell | S | 1.73 | 5,591 | 9,670 | 174,353 | 179.9 K to 174.4 K (-3.11 %) |
May 22 2019 | ADMP | Adamis Pharmaceuti ... | Moss Ronald B. | Chief Medical Offic ... | Sell | S | 1.77 | 8,741 | 15,464 | 276,255 | 285 K to 276.3 K (-3.07 %) |
May 22 2019 | ADMP | Adamis Pharmaceuti ... | Marguglio David J. | SVP and Chief Busin ... | Sell | S | 1.77 | 8,735 | 15,464 | 381,699 | 390.4 K to 381.7 K (-2.24 %) |
May 22 2019 | ADMP | Adamis Pharmaceuti ... | Hopkins Robert O | Chief Financial Off ... | Sell | S | 1.73 | 7,559 | 13,109 | 340,348 | 347.9 K to 340.3 K (-2.17 %) |
Mar 22 2019 | ADMP | Adamis Pharmaceuti ... | Moss Ronald B. | Chief Medical Offic ... | Sell | S | 2.27 | 6,647 | 15,075 | 284,996 | 291.6 K to 285 K (-2.28 %) |
Mar 22 2019 | ADMP | Adamis Pharmaceuti ... | Daniels Karen K. | VP of Operations | Sell | S | 2.30 | 13,911 | 32,011 | 179,944 | 193.9 K to 179.9 K (-7.18 %) |
Mar 22 2019 | ADMP | Adamis Pharmaceuti ... | CARLO DENNIS J PHD | President & CEO | Sell | S | 2.27 | 13,292 | 30,133 | 42,353 | 55.6 K to 42.4 K (-23.89 %) |
Mar 22 2019 | ADMP | Adamis Pharmaceuti ... | Hopkins Robert O | Chief Financial Off ... | Sell | S | 2.30 | 8,900 | 20,446 | 347,907 | 356.8 K to 347.9 K (-2.49 %) |
Mar 22 2019 | ADMP | Adamis Pharmaceuti ... | Marguglio David J. | SVP and Chief Busin ... | Sell | S | 2.28 | 10,579 | 24,107 | 390,434 | 401 K to 390.4 K (-2.64 %) |
Feb 25 2019 | ADMP | Adamis Pharmaceuti ... | Marguglio David J. | SVP and Chief Busin ... | Option Exercise | M | 0.00 | 22,258 | 0 | 44,515 | |
Feb 25 2019 | ADMP | Adamis Pharmaceuti ... | Marguglio David J. | SVP and Chief Busin ... | Buy | M | 0.00 | 22,258 | 0 | 401,013 | 378.8 K to 401 K (+5.88 %) |
Feb 25 2019 | ADMP | Adamis Pharmaceuti ... | Moss Ronald B. | Chief Medical Offic ... | Option Exercise | M | 0.00 | 13,911 | 0 | 27,822 | |
Feb 25 2019 | ADMP | Adamis Pharmaceuti ... | Moss Ronald B. | Chief Medical Offic ... | Buy | M | 0.00 | 13,911 | 0 | 291,643 | 277.7 K to 291.6 K (+5.01 %) |
Feb 25 2019 | ADMP | Adamis Pharmaceuti ... | Daniels Karen K. | VP of Operations | Option Exercise | M | 0.00 | 13,911 | 0 | 27,822 | |
Feb 25 2019 | ADMP | Adamis Pharmaceuti ... | Daniels Karen K. | VP of Operations | Buy | M | 0.00 | 13,911 | 0 | 193,855 | 179.9 K to 193.9 K (+7.73 %) |
Feb 25 2019 | ADMP | Adamis Pharmaceuti ... | Hopkins Robert O | Chief Financial Off ... | Option Exercise | M | 0.00 | 22,258 | 0 | 44,515 | |
Feb 25 2019 | ADMP | Adamis Pharmaceuti ... | Hopkins Robert O | Chief Financial Off ... | Buy | M | 0.00 | 22,258 | 0 | 356,807 | 334.5 K to 356.8 K (+6.65 %) |
Feb 25 2019 | ADMP | Adamis Pharmaceuti ... | CARLO DENNIS J PHD | President & CEO | Option Exercise | M | 0.00 | 27,822 | 0 | 55,645 | |
Feb 25 2019 | ADMP | Adamis Pharmaceuti ... | CARLO DENNIS J PHD | President & CEO | Buy | M | 0.00 | 27,822 | 0 | 388,883 | 361.1 K to 388.9 K (+7.71 %) |
Feb 01 2019 | ADMP | Adamis Pharmaceuti ... | DENBY WILLIAM C | Option Exercise | A | 3.09 | 30,000 | 92,700 | 30,000 | ||
Feb 01 2019 | ADMP | Adamis Pharmaceuti ... | Hopkins Robert O | Chief Financial Off ... | Grant | A | 0.00 | 277,732 | 0 | 334,549 | 56.8 K to 334.5 K (+488.82 %) |
Feb 01 2019 | ADMP | Adamis Pharmaceuti ... | CARLO DENNIS J PHD | President & CEO | Grant | A | 0.00 | 347,165 | 0 | 361,061 | 13.9 K to 361.1 K (+2,498.31 %) |
Feb 01 2019 | ADMP | Adamis Pharmaceuti ... | Daniels Karen K. | VP of Operations | Grant | A | 0.00 | 173,583 | 0 | 179,944 | 6.4 K to 179.9 K (+2,728.86 %) |
Feb 01 2019 | ADMP | Adamis Pharmaceuti ... | Marguglio David J. | Sr VP of Business D ... | Grant | A | 0.00 | 277,732 | 0 | 378,755 | 101 K to 378.8 K (+274.92 %) |
Feb 01 2019 | ADMP | Adamis Pharmaceuti ... | WILLIAMS RICHARD C | Option Exercise | A | 3.09 | 30,000 | 92,700 | 30,000 | ||
Feb 01 2019 | ADMP | Adamis Pharmaceuti ... | ROTHERMEL ROBERT B | Option Exercise | A | 3.09 | 30,000 | 92,700 | 30,000 | ||
Feb 01 2019 | ADMP | Adamis Pharmaceuti ... | Moss Ronald B. | Chief Medical Offic ... | Grant | A | 0.00 | 277,732 | 0 | 277,732 | 0 to 277.7 K |
Jul 11 2018 | ADMP | Adamis Pharmaceuti ... | DENBY WILLIAM C | Director | Option Exercise | A | 4.28 | 30,000 | 128,400 | 30,000 | |
Jul 11 2018 | ADMP | Adamis Pharmaceuti ... | WILLIAMS RICHARD C | Director | Option Exercise | A | 4.28 | 30,000 | 128,400 | 30,000 | |
Jul 11 2018 | ADMP | Adamis Pharmaceuti ... | ROTHERMEL ROBERT B | Director | Option Exercise | A | 4.28 | 30,000 | 128,400 | 30,000 | |
Feb 23 2018 | CLGY | Adamis Pharmaceuti ... | Glover Eddie Wabern | CEO of US Compoundi ... | Option Exercise | A | 2.83 | 35,000 | 99,050 | 35,000 | |
Feb 23 2018 | CLGY | Adamis Pharmaceuti ... | CARLO DENNIS J PHD | President & CEO | Option Exercise | A | 0.00 | 83,467 | 0 | 83,467 | |
Feb 23 2018 | CLGY | Adamis Pharmaceuti ... | CARLO DENNIS J PHD | President & CEO | Option Exercise | A | 2.83 | 166,934 | 472,423 | 166,934 | |
Feb 23 2018 | CLGY | Adamis Pharmaceuti ... | Moss Ronald B. | Chief Medical Offic ... | Option Exercise | A | 0.00 | 41,733 | 0 | 41,733 | |
Feb 23 2018 | CLGY | Adamis Pharmaceuti ... | Moss Ronald B. | Chief Medical Offic ... | Option Exercise | A | 2.83 | 83,467 | 236,212 | 83,467 | |
Feb 23 2018 | CLGY | Adamis Pharmaceuti ... | Marguglio David J. | Sr VP of Business D ... | Option Exercise | A | 0.00 | 66,773 | 0 | 66,773 | |
Feb 23 2018 | CLGY | Adamis Pharmaceuti ... | Marguglio David J. | Sr VP of Business D ... | Option Exercise | A | 2.83 | 133,547 | 377,938 | 133,547 | |
Feb 23 2018 | CLGY | Adamis Pharmaceuti ... | Daniels Karen K. | VP of Operations | Option Exercise | A | 0.00 | 41,733 | 0 | 41,733 | |
Feb 23 2018 | CLGY | Adamis Pharmaceuti ... | Daniels Karen K. | VP of Operations | Option Exercise | A | 2.83 | 83,467 | 236,212 | 83,467 | |
Feb 23 2018 | CLGY | Adamis Pharmaceuti ... | Hopkins Robert O | Chief Financial Off ... | Option Exercise | A | 0.00 | 66,773 | 0 | 66,773 | |
Feb 23 2018 | CLGY | Adamis Pharmaceuti ... | Hopkins Robert O | Chief Financial Off ... | Option Exercise | A | 2.83 | 133,547 | 377,938 | 133,547 | |
Feb 23 2018 | CLGY | Adamis Pharmaceuti ... | Moll Thomas | VP of Research | Option Exercise | A | 0.00 | 41,733 | 0 | 41,733 | |
Feb 23 2018 | CLGY | Adamis Pharmaceuti ... | Moll Thomas | VP of Research | Option Exercise | A | 2.83 | 83,467 | 236,212 | 83,467 | |
Jun 12 2017 | CLGY | Adamis Pharmaceuti ... | WILLIAMS RICHARD C | Director | Option Exercise | A | 4.10 | 30,000 | 123,000 | 30,000 | |
Jun 12 2017 | CLGY | Adamis Pharmaceuti ... | ROTHERMEL ROBERT B | Director | Option Exercise | A | 4.10 | 30,000 | 123,000 | 30,000 | |
Jun 12 2017 | CLGY | Adamis Pharmaceuti ... | DENBY WILLIAM C | Director | Option Exercise | A | 4.10 | 30,000 | 123,000 | 30,000 | |
Mar 16 2017 | CLGY | Adamis Pharmaceuti ... | Moss Ronald B. | Chief Medical Offic ... | Option Exercise | A | 3.45 | 210,000 | 724,500 | 210,000 | |
Mar 03 2017 | CLGY | Adamis Pharmaceuti ... | Daniels Karen K. | VP of Operations | Option Exercise | A | 0.00 | 150,000 | 0 | 150,000 | |
Mar 03 2017 | CLGY | Adamis Pharmaceuti ... | Moll Thomas | VP of Research | Option Exercise | A | 0.00 | 150,000 | 0 | 150,000 | |
Mar 03 2017 | CLGY | Adamis Pharmaceuti ... | Marguglio David J. | Sr VP of Business D ... | Option Exercise | A | 0.00 | 200,000 | 0 | 200,000 | |
Mar 03 2017 | CLGY | Adamis Pharmaceuti ... | Hopkins Robert O | Chief Financial Off ... | Option Exercise | A | 0.00 | 200,000 | 0 | 200,000 | |
Mar 03 2017 | CLGY | Adamis Pharmaceuti ... | CARLO DENNIS J PHD | President & CEO | Option Exercise | A | 0.00 | 250,000 | 0 | 250,000 | |
Feb 09 2017 | CLGY | Adamis Pharmaceuti ... | Moll Thomas | VP of Research | Option Exercise | A | 3.15 | 110,000 | 346,500 | 110,000 | |
Feb 09 2017 | CLGY | Adamis Pharmaceuti ... | CARLO DENNIS J PHD | President & CEO | Option Exercise | A | 3.15 | 477,000 | 1,502,550 | 477,000 | |
Feb 09 2017 | CLGY | Adamis Pharmaceuti ... | Daniels Karen K. | VP of Operations | Option Exercise | A | 3.15 | 110,000 | 346,500 | 110,000 | |
Feb 09 2017 | CLGY | Adamis Pharmaceuti ... | Marguglio David J. | Sr VP of Business D ... | Option Exercise | A | 3.15 | 176,000 | 554,400 | 176,000 | |
Feb 09 2017 | CLGY | Adamis Pharmaceuti ... | Hopkins Robert O | Chief Financial Off ... | Option Exercise | A | 3.15 | 110,000 | 346,500 | 110,000 | |
Jun 06 2016 | CLGY | Adamis Pharmaceuti ... | Marguglio David J. | SR. VP of Corporate ... | Sell | S | 9.00 | 700 | 6,301 | 101,527 | 102.2 K to 101.5 K (-0.68 %) |
May 27 2016 | CLGY | Adamis Pharmaceuti ... | Glover Eddie Wabern | CEO of U.S. Compoun ... | Option Exercise | A | 8.46 | 70,000 | 592,200 | 70,000 | |
May 27 2016 | CLGY | Adamis Pharmaceuti ... | WILLIAMS RICHARD C | Director | Option Exercise | A | 8.46 | 30,000 | 253,800 | 30,000 | |
May 27 2016 | CLGY | Adamis Pharmaceuti ... | WILLIAMS RICHARD C | Director | Grant | A | 0.00 | 150,000 | 0 | 189,918 | 39.9 K to 189.9 K (+375.77 %) |
May 27 2016 | CLGY | Adamis Pharmaceuti ... | ROTHERMEL ROBERT B | Director | Option Exercise | A | 8.46 | 30,000 | 253,800 | 30,000 | |
May 27 2016 | CLGY | Adamis Pharmaceuti ... | ROTHERMEL ROBERT B | Director | Grant | A | 0.00 | 100,000 | 0 | 127,000 | 27 K to 127 K (+370.37 %) |
May 27 2016 | CLGY | Adamis Pharmaceuti ... | DENBY WILLIAM C | Director | Option Exercise | A | 8.46 | 30,000 | 253,800 | 30,000 | |
May 27 2016 | CLGY | Adamis Pharmaceuti ... | DENBY WILLIAM C | Director | Grant | A | 0.00 | 100,000 | 0 | 102,500 | 2.5 K to 102.5 K (+4,000.00 %) |
May 18 2016 | CLGY | Adamis Pharmaceuti ... | Marguglio David J. | SR VP OF CORPORATE ... | Sell | S | 8.08 | 4,000 | 32,339 | 102,227 | 106.2 K to 102.2 K (-3.77 %) |
May 11 2016 | CLGY | Adamis Pharmaceuti ... | Marguglio David J. | SR VP of Corporate ... | Sell | S | 10.00 | 4,860 | 48,600 | 106,227 | 111.1 K to 106.2 K (-4.37 %) |
May 06 2016 | CLGY | Adamis Pharmaceuti ... | Marguglio David J. | SR VP of Corporate ... | Sell | S | 9.17 | 4,860 | 44,577 | 112,227 | 117.1 K to 112.2 K (-4.15 %) |
May 05 2016 | CLGY | Adamis Pharmaceuti ... | Marguglio David J. | SR VP of Corporate ... | Sell | S | 9.00 | 1,140 | 10,260 | 117,087 | 118.2 K to 117.1 K (-0.96 %) |
Apr 18 2016 | CLGY | Adamis Pharmaceuti ... | Marguglio David J. | SR VP of Corporate ... | Sell | S | 7.52 | 12,000 | 90,216 | 118,227 | 130.2 K to 118.2 K (-9.21 %) |
Apr 14 2016 | CLGY | Adamis Pharmaceuti ... | Glover Eddie Wabern | CEO of U.S. Compoun ... | Grant | A | 0.00 | 866,666 | 0 | 866,666 | 0 to 866.7 K |
Jan 27 2016 | CLGY | Adamis Pharmaceuti ... | Hopkins Robert O | Chief Financial Off ... | Option Exercise | A | 4.10 | 67,183 | 275,450 | 67,183 | |
Jan 27 2016 | CLGY | Adamis Pharmaceuti ... | Marguglio David J. | Sr VP of Business D ... | Option Exercise | A | 4.10 | 107,493 | 440,721 | 107,493 | |
Jan 27 2016 | CLGY | Adamis Pharmaceuti ... | Moll Thomas | VP of Research | Option Exercise | A | 4.10 | 67,183 | 275,450 | 67,183 | |
Jan 27 2016 | CLGY | Adamis Pharmaceuti ... | Daniels Karen K. | VP of Operations | Option Exercise | A | 4.10 | 67,183 | 275,450 | 67,183 | |
Jan 27 2016 | CLGY | Adamis Pharmaceuti ... | CARLO DENNIS J PHD | President & CEO | Option Exercise | A | 4.10 | 442,367 | 1,813,705 | 442,367 | |
Aug 17 2015 | CLGY | Adamis Pharmaceuti ... | WILLIAMS RICHARD C | Director | Buy | P | 3.26 | 9,800 | 31,930 | 39,918 | 30.1 K to 39.9 K (+32.54 %) |
Aug 17 2015 | CLGY | Adamis Pharmaceuti ... | ROTHERMEL ROBERT B | Director | Buy | P | 3.40 | 2,000 | 6,800 | 27,000 | 25 K to 27 K (+8.00 %) |
Aug 17 2015 | CLGY | Adamis Pharmaceuti ... | ROTHERMEL ROBERT B | Director | Buy | P | 3.30 | 5,000 | 16,494 | 25,000 | 20 K to 25 K (+25.00 %) |
May 18 2015 | CLGY | Adamis Pharmaceuti ... | ROTHERMEL ROBERT B | Director | Option Exercise | A | 4.28 | 20,000 | 85,600 | 20,000 | |
May 18 2015 | CLGY | Adamis Pharmaceuti ... | WILLIAMS RICHARD C | Director | Option Exercise | A | 4.28 | 20,000 | 85,600 | 20,000 | |
May 18 2015 | CLGY | Adamis Pharmaceuti ... | DENBY WILLIAM C | Director | Option Exercise | A | 4.28 | 20,000 | 85,600 | 20,000 | |
Apr 22 2015 | CLGY | Adamis Pharmaceuti ... | Marguglio David J. | Sr VP of Business D ... | Sell | S | 5.00 | 200 | 1,000 | 140,323 | 140.5 K to 140.3 K (-0.14 %) |
Apr 20 2015 | CLGY | Adamis Pharmaceuti ... | Marguglio David J. | Sr VP of Business D ... | Sell | S | 5.01 | 100 | 501 | 140,523 | 140.6 K to 140.5 K (-0.07 %) |
Apr 17 2015 | CLGY | Adamis Pharmaceuti ... | Marguglio David J. | Sr VP of Business D ... | Sell | S | 5.00 | 700 | 3,501 | 140,623 | 141.3 K to 140.6 K (-0.50 %) |
Apr 15 2015 | CLGY | Adamis Pharmaceuti ... | Marguglio David J. | Sr VP of Business D ... | Sell | S | 5.00 | 100 | 500 | 141,323 | 141.4 K to 141.3 K (-0.07 %) |
Apr 15 2015 | CLGY | Adamis Pharmaceuti ... | Marguglio David J. | Sr VP of Business D ... | Sell | S | 5.01 | 2,100 | 10,524 | 141,423 | 143.5 K to 141.4 K (-1.46 %) |
Mar 05 2015 | CLGY | Adamis Pharmaceuti ... | Marguglio David J. | Sr VP of Business D ... | Sell | S | 7.09 | 11,800 | 83,662 | 143,523 | 155.3 K to 143.5 K (-7.60 %) |
Mar 03 2015 | CLGY | Adamis Pharmaceuti ... | Marguglio David J. | Sr VP of Business D ... | Sell | S | 6.45 | 7,000 | 45,150 | 155,323 | 162.3 K to 155.3 K (-4.31 %) |
Feb 13 2015 | CLGY | Adamis Pharmaceuti ... | Rahman Ahmed Shayan Fazlur | 10% Owner | Sell | S | 6.41 | 12,076 | 77,395 | 1,635,312 | 1.6 M to 1.6 M (-0.73 %) |
Feb 12 2015 | CLGY | Adamis Pharmaceuti ... | Rahman Ahmed Shayan Fazlur | 10% Owner | Sell | S | 6.40 | 23,000 | 147,223 | 1,647,388 | 1.7 M to 1.6 M (-1.38 %) |
Feb 12 2015 | CLGY | Adamis Pharmaceuti ... | Rahman Ahmed Shayan Fazlur | 10% Owner | Sell | S | 6.40 | 10,000 | 64,000 | 1,670,388 | 1.7 M to 1.7 M (-0.60 %) |
Feb 12 2015 | CLGY | Adamis Pharmaceuti ... | Rahman Ahmed Shayan Fazlur | 10% Owner | Sell | S | 6.39 | 5,000 | 31,945 | 1,680,388 | 1.7 M to 1.7 M (-0.30 %) |
Feb 03 2015 | CLGY | Adamis Pharmaceuti ... | Rahman Ahmed Shayan Fazlur | 10% Owner | Sell | S | 6.67 | 20,000 | 133,380 | 1,685,388 | 1.7 M to 1.7 M (-1.17 %) |
Feb 03 2015 | CLGY | Adamis Pharmaceuti ... | Rahman Ahmed Shayan Fazlur | 10% Owner | Sell | S | 6.92 | 10,000 | 69,170 | 1,705,388 | 1.7 M to 1.7 M (-0.58 %) |
Jan 27 2015 | CLGY | Adamis Pharmaceuti ... | CARLO DENNIS J PHD | President & CEO | Option Exercise | A | 5.99 | 232,103 | 1,390,297 | 232,103 | |
Jan 27 2015 | CLGY | Adamis Pharmaceuti ... | Daniels Karen K. | VP of Operations | Option Exercise | A | 5.99 | 65,050 | 389,650 | 65,050 | |
Jan 27 2015 | CLGY | Adamis Pharmaceuti ... | Hopkins Robert O | Chief Financial Off ... | Option Exercise | A | 5.99 | 65,050 | 389,650 | 65,050 | |
Jan 27 2015 | CLGY | Adamis Pharmaceuti ... | Moll Thomas | VP of Research | Option Exercise | A | 5.99 | 65,050 | 389,650 | 65,050 | |
Jan 27 2015 | CLGY | Adamis Pharmaceuti ... | Marguglio David J. | Senior Vice Preside ... | Option Exercise | A | 5.99 | 119,910 | 718,261 | 119,910 | |
Jan 09 2015 | CLGY | Adamis Pharmaceuti ... | Marguglio David J. | Sr VP of Business D ... | Sell | S | 7.00 | 200 | 1,400 | 164,273 | 164.5 K to 164.3 K (-0.12 %) |